Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Greil

Showing results (221-230 of 483) with videos related to

Pageof 49
Sort By:
Breast Care (Basel, Switzerland)|March 31, 2022
Transferring MINDACT to Daily Routine: Implementation of the 70-Gene Signature in Luminal Early Breast Cancer - Results from a Prospective Registry of the Austrian Group Medical Tumor Therapy (AGMT)Theresa Westphal, Simon P Gampenrieder, Gabriel Rinnerthaler, et al.
British Journal of Haematology|October 18, 2005
Continuous prednisolone versus conventional prednisolone with VMCP-interferon-alpha2b as first-line chemotherapy in elderly patients with multiple myelomaHeinz Ludwig, Ivan Spicka, Pavel Klener, et al.
Oncotarget|July 8, 2016
CD1d expression on chronic lymphocytic leukemia B cells affects disease progression and induces T cell skewing in CD8 positive and CD4CD8 double negative T cellsNadja Zaborsky, Franz Josef Gassner, Daniela Asslaber, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2010
Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphomaOlaf Merkel, Frank Hamacher, Daniela Laimer, et al.
British Journal of Haematology|September 20, 2014
A modified scoring of the NCCN-IPI is more accurate in the elderly and is improved by albumin and β2 -microglobulinThomas Melchardt, Katharina Troppan, Lukas Weiss, et al.
Anticancer Research|February 28, 2023
Real-world Data of Palliative First-line Checkpoint Inhibitor Therapy for Head and Neck CancerSandro M Wagner, Teresa Magnes, Thomas Melchardt, et al.
Lancet (London, England)|August 9, 2005
Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trialRaimund Jakesz, Walter Jonat, Michael Gnant, et al.
European Journal of Haematology|December 16, 2019
Treatment with brentuximab vedotin plus bendamustine in unselected patients with CD30-positive aggressive lymphomasSandro M Wagner, Thomas Melchardt, Alexander Egle, et al.
Future Science OA|January 13, 2021
Overcoming negative predictions of microRNA expressions to gemcitabine response with FOLFIRINOX in advanced pancreatic cancer patientsKonstantin Schlick, Florian Hohla, Frank Hamacher, et al.
Wiener Klinische Wochenschrift|January 1, 2009
Diagnostic algorithms, monitoring, prognostication, and therapy in chronic myeloid leukemia (CML): a proposal of the Austrian CML platformPeter Valent, Thomas Lion, Dominik Wolf, et al.
Pageof 49

Showing results (221-230 of 483) with videos related to

Sort By:
Pageof 49
Breast Care (Basel, Switzerland)|March 31, 2022
Transferring MINDACT to Daily Routine: Implementation of the 70-Gene Signature in Luminal Early Breast Cancer - Results from a Prospective Registry of the Austrian Group Medical Tumor Therapy (AGMT)Theresa Westphal, Simon P Gampenrieder, Gabriel Rinnerthaler, et al.
British Journal of Haematology|October 18, 2005
Continuous prednisolone versus conventional prednisolone with VMCP-interferon-alpha2b as first-line chemotherapy in elderly patients with multiple myelomaHeinz Ludwig, Ivan Spicka, Pavel Klener, et al.
Oncotarget|July 8, 2016
CD1d expression on chronic lymphocytic leukemia B cells affects disease progression and induces T cell skewing in CD8 positive and CD4CD8 double negative T cellsNadja Zaborsky, Franz Josef Gassner, Daniela Asslaber, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2010
Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphomaOlaf Merkel, Frank Hamacher, Daniela Laimer, et al.
British Journal of Haematology|September 20, 2014
A modified scoring of the NCCN-IPI is more accurate in the elderly and is improved by albumin and β2 -microglobulinThomas Melchardt, Katharina Troppan, Lukas Weiss, et al.
Anticancer Research|February 28, 2023
Real-world Data of Palliative First-line Checkpoint Inhibitor Therapy for Head and Neck CancerSandro M Wagner, Teresa Magnes, Thomas Melchardt, et al.
Lancet (London, England)|August 9, 2005
Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trialRaimund Jakesz, Walter Jonat, Michael Gnant, et al.
European Journal of Haematology|December 16, 2019
Treatment with brentuximab vedotin plus bendamustine in unselected patients with CD30-positive aggressive lymphomasSandro M Wagner, Thomas Melchardt, Alexander Egle, et al.
Future Science OA|January 13, 2021
Overcoming negative predictions of microRNA expressions to gemcitabine response with FOLFIRINOX in advanced pancreatic cancer patientsKonstantin Schlick, Florian Hohla, Frank Hamacher, et al.
Wiener Klinische Wochenschrift|January 1, 2009
Diagnostic algorithms, monitoring, prognostication, and therapy in chronic myeloid leukemia (CML): a proposal of the Austrian CML platformPeter Valent, Thomas Lion, Dominik Wolf, et al.
Pageof 49